Wolverine Trading, LLC Crispr Therapeutics Ag Put Options Transaction History

Wolverine Trading, LLC

$93.9 Billion
Q3 2024

Put Options

24 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	SELL	$44.62 - $62.75 $361,422 - $508,275	-8,100 Reduced 16.8%	40,100 $1.88 Million
Q2 2024 Aug 14, 2024	SELL	$51.17 - $68.18 $363,307 - $484,078	-7,100 Reduced 12.84%	48,200 $2.6 Million
Q1 2024 May 15, 2024	SELL	$60.67 - $89.12 $370,087 - $543,632	-6,100 Reduced 9.93%	55,300 $3.77 Million
Q4 2023 Feb 14, 2024	BUY	$38.62 - $72.18 $849,640 - $1.59 Million	22,000 Added 55.84%	61,400 $3.84 Million
Q2 2023 Aug 23, 2023	BUY	$43.47 - $67.77 $708,561 - $1.1 Million	16,300 Added 70.56%	39,400 $2.21 Million
Q1 2023 May 15, 2023	BUY	$41.0 - $56.12 $65,600 - $89,792	1,600 Added 7.44%	23,100 $1.02 Million
Q4 2022 Feb 14, 2023	SELL	$39.19 - $65.67 $223,383 - $374,319	-5,700 Reduced 20.96%	21,500 $874,000
Q3 2022 Nov 14, 2022	SELL	$61.1 - $83.78 $1.05 Million - $1.44 Million	-17,200 Reduced 38.74%	27,200 $1.75 Million
Q2 2022 Aug 15, 2022	BUY	$43.23 - $73.83 $12,968 - $22,149	300 Added 0.68%	44,400 $2.8 Million
Q1 2022 May 16, 2022	SELL	$53.19 - $79.24 $1.66 Million - $2.47 Million	-31,200 Reduced 41.43%	44,100 $2.83 Million
Q4 2021 Feb 14, 2022	SELL	$70.09 - $111.29 $294,378 - $467,418	-4,200 Reduced 5.28%	75,300 $5.94 Million
Q3 2021 Nov 12, 2021	SELL	$110.2 - $156.64 $1.81 Million - $2.57 Million	-16,400 Reduced 17.1%	79,500 $8.76 Million
Q2 2021 Aug 06, 2021	BUY	$100.84 - $161.89 $655,460 - $1.05 Million	6,500 Added 7.27%	95,900 $14.4 Million
Q1 2021 May 14, 2021	BUY	$110.72 - $210.04 $3.04 Million - $5.78 Million	27,500 Added 44.43%	89,400 $10.3 Million
Q4 2020 Feb 12, 2021	BUY	$79.67 - $173.23 $2.65 Million - $5.75 Million	33,200 Added 115.68%	61,900 $10 Million
Q3 2020 Nov 13, 2020	SELL	$78.5 - $100.64 $384,650 - $493,136	-4,900 Reduced 14.58%	28,700 $2.44 Million
Q2 2020 Aug 13, 2020	BUY	$38.5 - $76.05 $273,350 - $539,955	7,100 Added 26.79%	33,600 $2.52 Million
Q1 2020 May 11, 2020	BUY	$33.68 - $62.53 $215,552 - $400,192	6,400 Added 31.84%	26,500 $1.17 Million
Q4 2019 Feb 12, 2020	SELL	$36.68 - $73.13 $33,012 - $65,817	-900 Reduced 4.29%	20,100 $1.24 Million
Q3 2019 Nov 14, 2019	SELL	$40.99 - $52.56 $323,821 - $415,224	-7,900 Reduced 27.34%	21,000 $890,000
Q2 2019 Aug 20, 2019	BUY	$35.45 - $48.2 $187,885 - $255,460	5,300 Added 22.46%	28,900 $1.36 Million
Q1 2019 May 15, 2019	BUY	$28.02 - $40.87 $173,724 - $253,393	6,200 Added 35.63%	23,600 $843,000
Q4 2018 Feb 14, 2019	SELL	$22.73 - $42.34 $186,386 - $347,188	-8,200 Reduced 32.03%	17,400 $465,000
Q3 2018 Nov 14, 2018	BUY	$44.35 - $65.71 $1.14 Million - $1.68 Million	25,600 New	25,600 $1.14 Million

Others Institutions Holding CRSP

# of Institutions

490

Shares Held

58M

Call Options Held

1.1M

Put Options Held

1.9M

Capital International Investors Los Angeles, CA

7.93M
Shares

$306 Million
0.07% of portfolio
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl

7.5M
Shares

$290 Million
3.35% of portfolio
State Street Corp Boston, MA

2.99M
Shares

$116 Million
0.01% of portfolio
Sumitomo Mitsui Trust Holdings, Inc.

2.97M
Shares

$115 Million
0.1% of portfolio
Nikko Asset Management Americas, Inc.

2.97M
Shares

$115 Million
1.61% of portfolio

View Full List

About CRISPR Therapeutics AG

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.02B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

More about CRSP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.

Account